摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

bis-(3-morpholino-propyl)-amine | 18889-29-7

中文名称
——
中文别名
——
英文名称
bis-(3-morpholino-propyl)-amine
英文别名
3-morpholin-4-yl-N-(3-morpholin-4-ylpropyl)propan-1-amine
bis-(3-morpholino-propyl)-amine化学式
CAS
18889-29-7
化学式
C14H29N3O2
mdl
——
分子量
271.403
InChiKey
NRIAQGAVWHTZJV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    185 °C(Press: 5 Torr)
  • 密度:
    1.021±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -0.2
  • 重原子数:
    19
  • 可旋转键数:
    8
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    37
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] BIARYLTRIAZOLE INHIBITORS OF MACROPHAGE MIGRATION INHIBITORY FACTOR<br/>[FR] INHIBITEURS DE TRIAZOLE BIARYLE DU FACTEUR INHIBITEUR DE LA MIGRATION DES MACROPHAGES
    申请人:UNIV YALE
    公开号:WO2016130968A1
    公开(公告)日:2016-08-18
    The present disclosure describes biaryl triazole compounds, as well as their compositions and methods of use. The compounds inhibit the activity of macrophage migration inhibitory factor and are useful for the treatment of diseases, e.g., inflammatory diseases and cancer.
    本公开描述了联苯三唑化合物,以及它们的组合物和使用方法。这些化合物抑制巨噬细胞迁移抑制因子的活性,并且对于治疗疾病,例如炎症性疾病和癌症,具有用处。
  • OPTICAL RECORDING MEDIUM AND COMPOUND USED FOR THE SAME
    申请人:SHIOZAKI Hiroyoshi
    公开号:US20090306376A1
    公开(公告)日:2009-12-10
    A compound comprising a ring structure including a ring composed of four carbon atoms and two nitrogen atoms and a substituted or unsubstituted amino group bonded to the ring structure.
    一种化合物,包括一个环结构,其中包括由四个碳原子和两个氮原子组成的环,以及与环结构相结合的取代或未取代的基团。
  • Derivatives of alkylaminoalkyl ureas and cyanoguanidines
    申请人:A.H. ROBINS COMPANY, INCORPORATED
    公开号:EP0295010A1
    公开(公告)日:1988-12-14
    Compounds of general formula I wherein, Ar represents a 1-naphthyl group, a 2-naphthyl group, a 2,3-dihydro-1 H-inden-4(or 5)-yl group, a 2-furanylmethyl group, a 2-pyridinyl group, a phenyl group or a phenyl substituted by one to three substituents wherein the or each substituent independently represents a loweralkyl group, a loweralkoxy group, a diloweralkylamino group, a cyano group, a loweralkylthio group, a loweralkylsulfinyl group, a loweralkylsulfonyl group, an acyl group, an acylamino group, an aminocarbonyl group, a diloweral- kylaminoloweralkoxy group, a trifluoromethyl group, a nitro group or a halogen atom; X represents a thio group, a sulfinyl group, a sulfonyl group or an oxygen atom; d represents zero or one; B represents a carbonyl group, a thioxomethyl group or a cyanoiminomethyl group; each of n, m and p independently represents an integer from 2 to 6 inclusive; each of Z and W independently represent an R group or a group with the proviso that when Z represents R, W represents a -(CH2)m-NR1R2 group and when Z represents (CH2)m-NR1R2, W represents R; each of R, R1, R2, R3 and R4 independently represents a hydrogen atom, a loweralkyl group, a cycloalkyl group, a phenyl group or a phenylloweralkyl group wherein phenyl may be substituted by one to three radicals wherein each radical independently represents a loweralkyl group, a loweralkoxy group, a cyano group, a trifluoromethyl group, a nitro group or a halogen atom or each of R1 and R2, and R3 and R4 may, together with the adjacent nitrogen atom form the heterocyclic ring structure 1-homopiperidinyl, 1-piperidinyl, 4-morpholinyl, 1-pyrrolidinyl, 1-piperazinyl, or 4-substituted-1-piperazinyl; with the further proviso that some meanings given for the symbols must not be realized simultaneously, as indicated specifically in claim 1, or the pharmaceutically acceptable salts thereof are useful in the treatment of cardiac arrhythmia.
    通式 I 的化合物 其中 Ar 代表 1-基、2-基、2,3-二氢-1 H--4(或 5)-基、2-呋喃甲基、2-吡啶基、苯基或被一至三个取代基取代的苯基,其中或每个取代基独立地代表低级烷基、一个低级烷氧基、一个低级烷基、一个基、一个低级烷基、一个低级烷基亚磺基、一个低级烷基磺酰基、一个酰基、一个酰基、一个基羰基、一个低级烷基低级烷氧基、一个三甲基、一个硝基或一个卤原子; X 代表代基团、亚砜基团、磺酰基团或氧原子; d 代表 0 或 1; B 代表羰基、氧甲基或基甲基; n、m 和 p 各自独立地代表 2 至 6(含 6)的整数 Z和W各自独立地代表一个R基团或一个 但当 Z 代表 R 时,W 代表-(CH2)m-NR1R2 基团;当 Z 代表 ( )m-NR1R2 时,W 代表 R; R、R1、R2、R3 和 R4 各自独立地代表氢原子、低级烷基、环烷基、苯基或苯基低级烷基,其中苯基可被一至三个基团取代,每个基团独立地代表低级烷基、低级烷氧基、基、三甲基、硝基或卤素原子或 R1 和 R2 以及 R3 和 R4 中的每一个可与相邻的氮原子一起形成杂环结构 1-高哌啶基、1-哌啶基、4-吗啉基、1-吡咯烷基、1-哌嗪基或 4-取代-1-哌嗪基; 进一步的但书是,如权利要求 1 中特别指出的,符号的某些含义不得同时实现,或其药学上可接受的盐类可用于治疗心律失常。
  • OPTICAL RECORDING MEDIUM AND COMPOUND USED IN THE OPTICAL RECORDING MEDIUM
    申请人:Mitsui Chemicals, Inc.
    公开号:EP1672626A1
    公开(公告)日:2006-06-21
    There are provided an optical recording medium which enables recording and playback with high quality using laser of 300 nm to 900 nm and a novel compound. An optical recording medium wherein the percentage change (|[a2 - a1]/a1| × 100) of the recording layer thickness (a2) at the recorded site of recording layer (A) after recorded with laser light compared with the recording layer thickness (a1) at unrecorded site of said recording layer (A) is less than 25% and the amount of change (|a2 - a1|) of the recording layer thickness (a2) at recorded site of said recording layer (A) after recorded with laser light compared with the recording layer thickness (a1) at unrecorded site of said recording layer (A) is controlled to be less than 15 nm. A compound comprising a six-membered ring structure composed of four carbon atoms and two nitrogen atoms and a substituted or unsubstituted amino group bonded.
    本发明提供了一种光学记录介质,利用波长为 300 纳米至 900 纳米的激光和一种新型化合物可实现高质量的记录和重放。 一种光学记录介质,其中用激光记录后,记录层(A)的记录部位的记录层厚度(a2)与未记录部位的记录层厚度(a1)相比的变化百分比(|[a2-a1]/a1| ×100)小于 25%,且所述记录层(A)的记录部位的记录层厚度(a2)与未记录部位的记录层厚度(a1)相比的变化量(|a2-a1|)小于 25%。a1|)的变化量控制在 15 nm 以下。 一种由四个碳原子和两个氮原子以及一个取代或未取代的基键合而成的六元环结构的化合物。
  • Optical data medium containing, in the information layer, a phthalocyanine dye as a light-absorbing compound
    申请人:——
    公开号:US20020076648A1
    公开(公告)日:2002-06-20
    The invention relates to an optical data medium containing a preferably transparent substrate that is optionally already coated with one or more reflective layers and on the surface of which have been applied: (1) an information layer that can be recorded on using light, wherein the information layer contains at least one phthalocyanine light-absorbing compound and optionally a binder, (2) optionally one or more reflective layers, and (3) optionally a protective layer or a further substrate or a covering layer wherein the optical data medium can be recorded on and read using blue light, preferably laser light.
    本发明涉及一种光学数据介质,该介质包含一个最好是透明的基底,该基底可选地已经涂有一层或多层反射层,并在其表面涂有以下涂层: (1) 可以用光记录的信息层,其中信息层含有至少一种酞菁光吸收化合物和粘合剂、 (2) 可选的一个或多个反射层,以及 (3) 可选的保护层或进一步的基底或覆盖层 其中,光学数据介质可以用蓝光(最好是激光)记录和读取。
查看更多